Detalhe da pesquisa
1.
The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.
Pathogens
; 12(12)2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38133292
2.
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A.
J Inflamm Res
; 9: 39-50, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143947
3.
LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth.
Clin Cancer Res
; 20(23): 6059-70, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25231402
4.
Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20.
Blood
; 102(9): 3206-9, 2003 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12855566